The 2026 Healthtech Messaging Index

Rank#22of 302

Eko Health

ekohealth.com·scored November 1, 2026

74out of 100

28/38

Approaching

Close. The bones are good. A few targeted fixes on the weakest signals would push Eko Health into magnetic territory.

ApproachingAI recommends them? Yes
Eko Health homepage

The page we scored

The AI Recommendation Check

When we asked AI who to recommend for AI-enabled digital stethoscope and cardiac diagnostic technology for clinical and health system use, it named:

Buyer we put in the prompt: Clinician (physician, nurse, EMS provider) or health system administrator/VP of Digital Health at a hospital or integrated health system. Both the buyer and the category were inferred from Eko Health’s homepage alone. The model had no web access.

Stethio by Eko3M Littmann (CORE Digital Stethoscope)WithingsCaption HealthCardiac AI (Cardiologs)AliveCorPhilips Healthcare

Eko Health was on the list.

AI named them for their own category. That's the signal every homepage is supposed to send.

AI named you when asked who it recommends for "AI-enabled digital stethoscope and cardiac diagnostic technology for clinical and health system use", and described you accurately: "Eko Health makes AI-powered digital stethoscopes that amplify heart and lung sounds and use machine learning algorithms to help clinicians detect cardiac conditions such as murmurs and atrial fibrillation at the point of care.". Your positioning is landing with the machines.

Overall assessment

Eko Health's biggest strength is its evidence stack ... a 2x detection claim cited to a 2026 Lancet study, 10 FDA clearances, TIME recognition, and named health system testimonials give it rare third-party credibility for an AI health company. The biggest gap is conversion architecture: there is no clear primary vs. secondary CTA path, no acknowledgment of alternatives or competitors, and the ICP is too diffuse ... individual clinicians and enterprise health system buyers are addressed interchangeably with no segmented journey, leaving enterprise prospects especially without a clear next step.

Signal by category

Narrative Clarity

8 signals

10/16

Trust Signal

4 signals

6/8

AI Signal

6 signals

11/12

Conversion Signal

1 signal

1/2
0

Weakest signal · fix this first

12Alternatives Acknowledged

“No mention of competitors, alternative solutions, or 'do nothing' option anywhere on the page.”

The page never acknowledges that buyers could choose a traditional stethoscope, a competitor like 3M Littmann, or simply do nothing ... alternatives are entirely absent.

All 19 signals, scored 0 to 2.

Narrative Clarity

8 signals

10/16
  • 01The 7-Second Test

    “A new kind of stethoscope that brings traditional and digital listening together.”

    The hero communicates product category and a vague innovation angle, but fails to name who it's for or what specific problem it solves within 7 seconds ... 'a new kind of stethoscope' is not a problem statement.

    1
  • 02Rebellion / Movement

    “200 years of tradition. One big twist.”

    There's an implied rebellion against the outdated analog stethoscope, but the enemy ... stagnant cardiology diagnostics, missed diagnoses ... is never explicitly named or framed as a movement the company is leading against.

    1
  • 03Owned Language & Category

    “SENSORA®" and "CORE 300" and "CORE 500" appear as product names but no owned category frame is established.”

    Eko has registered product names but coins no new category term or framework that AI would quote back; 'AI-enabled stethoscope' is commodity language, not an owned frame.

    1
  • 04ICP Clarity

    “Works across specialties" and mentions "physicians, nurses, EMS professionals, students”

    The ICP is gestured at but too broad ... physicians, nurses, EMS, students, and health systems are all listed without indicating which is primary, what size organization, or what stage of digital maturity.

    1
  • 05Problem Leadership

    “Over 60% of heart diseases go undiagnosed.”

    The page leads with a stark, cited buyer problem in plain language before presenting the solution, which is effective problem leadership.

    2
  • 06Solution Clarity

    “We created a modern replacement for the stethoscope, and paired it with clinically proven AI and health system integrations for earlier disease detection.”

    This sentence is specific enough that a visitor can repeat the core solution in one sentence after reading it.

    2
  • 07Cost of Inaction

    “missing the warning signs of disease can lead to serious complications and outcomes.”

    The cost of inaction is vaguely named ('serious complications and outcomes') but not quantified or made viscerally real ... no mortality rates, missed diagnoses per year, or liability consequences are cited.

    1
  • 08Promised Land

    “detect with precision and treat with confidence”

    The promised land is sketched in generic clinical confidence language but lacks a specific, vivid 'after' state ... no concrete workflow transformation, patient outcome delta, or day-in-the-life picture is painted.

    1

Trust Signal

4 signals

6/8
  • 09Proof & Evidence

    “Providers who use Eko are 2x more likely to detect heart disease." and "750,000 devices sold" and "70+ publications”

    Multiple concrete, cited numbers including a sourced 2x detection outcome delta, device volume, and peer-reviewed publication count make this one of the strongest sections on the page.

    2
  • 10Social Proof

    “Albert C., VP and Chief of Digital Patient Experience, Sutter Health" and "Jagmeet S., Chief of Nephrology, Guthrie”

    Testimonials include named individuals, titles, and named health systems, with a video customer story (Wayne General Hospital) also referenced ... this is above average social proof for the category.

    2
  • 11Authority & Credibility

    “TIME: World's Top HealthTech Companies of 2026" and "The Lancet Publishes TRICORDER Study" and "10 FDA Clearances”

    Third-party validation from TIME, The Lancet, and FDA clearances constitutes demonstrated authority, not merely claimed expertise.

    2
  • 12Alternatives Acknowledgedweakest

    “No mention of competitors, alternative solutions, or 'do nothing' option anywhere on the page.”

    The page never acknowledges that buyers could choose a traditional stethoscope, a competitor like 3M Littmann, or simply do nothing ... alternatives are entirely absent.

    0

AI Signal

6 signals

11/12
  • 13Customer Focus

    “You know the difference between illness and health can be subtle" and "I feel I'm a better clinician.”

    The page tilts toward the customer in the problem section and testimonials but reverts to company-centric language ('We created,' 'Eko AI helps') throughout the features section, making it a mixed protagonist.

    1
  • 14AI-Parmesan Index

    “FDA-cleared AI to detect structural murmurs, AFib, and low ejection fraction" cited to "Rancier et al. 2026, European Heart Journal”

    AI claims are specific and mechanistic ... named conditions detected, FDA clearance status, and peer-reviewed citations ... not vague 'AI-powered' sprinkle language.

    2
  • 15LLM Quotability

    “Providers who use Eko are 2x more likely to detect heart disease." and "Over 60% of heart diseases go undiagnosed.”

    These are clean, declarative, citation-backed sentences an LLM could lift verbatim to recommend Eko when answering queries about cardiac diagnostic tools.

    2
  • 16Copyright Freshness

    “TIME: World's Top HealthTech Companies of 2026" and "Rancier et al. 2026" and recent blog dates visible”

    The page references 2026-dated awards, a 2026 peer-reviewed study, and recent product launches, providing strong recency signals for AI engines.

    2
  • 17Entity Distinctiveness

    “TRICORDER Study" in The Lancet, "SENSORA®" product, "10 FDA Clearances," "2x more likely to detect heart disease”

    The combination of a named proprietary clinical study, registered product names, specific FDA clearance count, and a quantified detection outcome delta makes Eko distinctly attributable and not interchangeable with generic competitors.

    2
  • 18AI Recommendation Check

    “AI described you as: "Eko Health makes AI-powered digital stethoscopes that amplify heart and lung sounds and use machine learning algorithms to help clinicians detect cardiac conditions such as murmurs and atrial fibrillation at the point of care.”

    AI named you when asked who it recommends for "AI-enabled digital stethoscope and cardiac diagnostic technology for clinical and health system use", and described you accurately: "Eko Health makes AI-powered digital stethoscopes that amplify heart and lung sounds and use machine learning algorithms to help clinicians detect cardiac conditions such as murmurs and atrial fibrillation at the point of care.". Your positioning is landing with the machines.

    2

Conversion Signal

1 signal

1/2
  • 19Path & CTA Clarity

    “LEARN MORE" and "SHOP NOW" CTAs present; no numbered process or soft secondary path for enterprise buyers.”

    There are two CTAs in the hero but they're parallel rather than primary/secondary, and there's no visible numbered process guiding the buyer ... enterprise health system visitors especially have no clear next step differentiated from individual clinician buyers.

    1

Keep the lead

AI already names Eko Health. The next edition decides if it still does.

Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing Eko Health the AI recommendation, and what to write instead.

Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.

← Back to the full Healthtech index

We revamp websites that ChatGPT ignores.

See the 90-Day AI Website Rebuild →